Zongyang Yu

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• Comprehensive analysis of transcriptomics and radiomics revealed the potential of TEDC2 as a diagnostic marker for lung adenocarcinoma.
  2024 L1 80/100

1 assessed by us (1 reproduced) · 37 not yet assessed — every PubMed paper on record, linked below.

• Pre-screening value of serum albumin and the glucose-lymphocyte ratio as the “transport-activation” effectors of immune checkpoint inhibitors in small cell lung cancer ↗

  Translational Lung Cancer Research · 2025 · PMID 41132963
  not yet assessed
• Expert Consensus on the Diagnosis and Treatment of Malignant Mesothelioma of the Tunica Vaginalis Testis ↗

  iMetaMed · 2025
  not yet assessed
• Expert Consensus on the Diagnosis and Treatment of Malignant Pericardial Mesothelioma ↗

  Med Research · 2025
  not yet assessed
• Comprehensive analysis of transcriptomics and radiomics revealed the potential of TEDC2 as a diagnostic marker for lung adenocarcinoma

  PeerJ · 2024 · PMID 39553728
  L1 80/100
• International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease ↗

  Translational Lung Cancer Research · 2023 · PMID 37691866
  not yet assessed
• NνDEx-100 conceptual design report ↗

  Nuclear Science and Techniques · 2023
  not yet assessed
• Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma ↗

  Thoracic Cancer · 2023 · PMID 37461124
  not yet assessed
• Aggressive Progression to EGFR Tyrosine Kinase inhibitors in Advanced NSCLC Patients: Concomitant Mutations, Prognostic Indicator and Subsequent Management ↗

  Research Square · 2023
  not yet assessed
• Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor ↗

  Thoracic Cancer · 2022 · PMID 36268845
  not yet assessed
• Chinese expert consensus on the diagnosis and treatment of <scp>HER2</scp>‐altered non–small cell lung cancer ↗

  Thoracic Cancer · 2022 · PMID 36444143
  not yet assessed
• Silencing LncRNA CASC9 inhibits proliferation and invasion of colorectal cancer cells by MiR-542-3p/ILK ↗

  PLoS ONE · 2022 · PMID 35427373
  not yet assessed
• Genetic alteration and PD-L1 expression profiles of Chinese patients with lung squamous cell carcinoma ↗

  Pathology - Research and Practice · 2022 · PMID 35151031
  not yet assessed
• Efficacy of Pemetrexed-Based Chemotherapy in Advanced NSCLC Chinese Patients with NRG1 Fusions by TNA Sequencing: A Multicenter Study ↗

  SSRN Electronic Journal · 2022
  not yet assessed
• Lung adenocarcinoma with active pulmonary tuberculosis: a case report of successful immunotherapy and systematical review ↗

  Research Square · 2021
  not yet assessed
• The deep learning model combining CT image and clinicopathological information for predicting ALK fusion status and response to ALK-TKI therapy in non-small cell lung cancer patients ↗

  European Journal of Nuclear Medicine and Molecular Imaging · 2020 · PMID 32794105
  not yet assessed
• Hesperetin reverses P‑glycoprotein‑mediated cisplatin resistance in DDP‑resistant human lung cancer cells via modulation of the nuclear factor‑κB signaling pathway ↗

  International Journal of Molecular Medicine · 2020 · PMID 32124932
  not yet assessed
• Association Between RET Fusions and Efficacy of Pemetrexed-based Chemotherapy for Patients With Advanced NSCLC in China: A Multicenter Retrospective Study ↗

  Clinical Lung Cancer · 2020 · PMID 32143967
  not yet assessed
• Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer ↗

  Frontiers in Oncology · 2020 · PMID 33163403
  not yet assessed
• Abstract 38: Large-scale study of NTRK fusions in Chinese solid tumors and using next generation sequencing: A multicenter study ↗

  Cancer Research · 2020
  not yet assessed
• Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study ↗

  Lung Cancer · 2019 · PMID 31775086
  not yet assessed
• Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study ↗

  Journal of Translational Medicine · 2019 · PMID 30791921
  not yet assessed
• Transcriptome‑wide piRNA profiling in human gastric cancer ↗

  Oncology Reports · 2019 · PMID 30896887
  not yet assessed
• Abstract 1597: Real-world large-scale study kinase domain duplications across diverse tumor types in Chinese populations ↗

  Cancer Research · 2019
  not yet assessed
• An EGFR extracellular domain mutation data in the East Asian non-small cell lung cancer populations and response to icotinib: A multicenter study. ↗

  Journal of Clinical Oncology · 2019
  not yet assessed
• De Novo MET Amplification in Chinese Patients With Non–Small-Cell Lung Cancer and Treatment Efficacy With Crizotinib: A Multicenter Retrospective Study ↗

  Clinical Lung Cancer · 2018 · PMID 30554986
  not yet assessed
• Next-generation sequencing of circulating tumor DNA for detection of gene mutations in lung cancer: implications for precision treatment ↗

  OncoTargets and Therapy · 2018 · PMID 30588023
  not yet assessed
• Potential challenge for second-line treatments of unresectable locally or advanced-stage non-small-cell lung carcinoma unharbored sensitive driver gene mutation: A pilot study of novel antiangiogenesis inhibitor (NCT: 0325672121). ↗

  Journal of Clinical Oncology · 2018
  not yet assessed
• [Improvement of survival quality of the patients with hemodialysis treated with moxibustion for regulating spleen and stomach functions: multi-central randomized controlled study]. ↗

  PubMed · 2014 · PMID 24946626
  not yet assessed
• CacyBP/SIP enhances multidrug resistance of pancreatic cancer cells by regulation of P-gp and Bcl-2 ↗

  APOPTOSIS · 2013 · PMID 23463283
  not yet assessed
• Regulation and expression of aberrant methylation on irinotecan metabolic genes CES2, UGT1A1 and GUSB in the in-vitro cultured colorectal cancer cells ↗

  Biomedicine & Pharmacotherapy · 2013 · PMID 24439671
  not yet assessed
• Initial outcome of induction chemotherapy followed by radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer ↗

  The Chinese-German Journal of Clinical Oncology · 2013
  not yet assessed
• Applied research on serum protein fingerprints for prediction of Qi deficiency syndrome and phlegm and blood stasis in patients with non-small cell lung cancer ↗

  中医杂志：英文版 · 2012 · PMID 23297554
  not yet assessed
• Effect of Feitai Capsule (肺泰胶囊) on quality of life and progression-free survival of patients with unresectable non-small cell lung cancer ↗

  Chinese Journal of Integrative Medicine · 2012 · PMID 22311406
  not yet assessed
• Clinical application of OxyContin hydrochloride controlled release tablets in treatment of pain suffered from advanced cancer ↗

  The Chinese-German Journal of Clinical Oncology · 2012
  not yet assessed
• Biochemical Analysis of Beagle Serum and Fetal Bovine Serum and the Biological Effect on Lung Carcinoma Cell Line in Vitro

  Zhongguo bijiao yixue zazhi · 2009
  not yet assessed
• Clinical randomized comparative trial of DICE regimen and CHOP regimen in treating intermediate and high grade non-Hodgkin’s lymphoma ↗

  The Chinese-German Journal of Clinical Oncology · 2008
  not yet assessed
• [Gemcitabine combined with capecitabine in the treatment for 41 patients with relapsed or metastatic biliary tract carcinoma]. ↗

  PubMed · 2008 · PMID 18646701
  not yet assessed
• [The inhibitory effects at the α-strain of insulin-like growth factor 1 receptor on SPCA-1 and A549 lung adenocarcinoma cell lines]. ↗

  PubMed · 2007 · PMID 21129298
  not yet assessed